לוסק 10 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

OMEPRAZOLE 10.0 MG

Disponible depuis:

ABIC LTD.

Code ATC:

A02BC01

forme pharmaceutique:

CAPSULES

Mode d'administration:

PER OS

Fabriqué par:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Groupe thérapeutique:

OMEPRAZOLE

indications thérapeutiques:

- Acute Duodenal Ulcer. - Acute Gastric Ulcer. - Helicobacter Pylori-Associated Peptic Ulcer Disease in combination with antibiotics. - Reflux Esophagitis:• Treatment;• Long-Term Management;• Maintenance Treatment for the Prevention of Relapse in Patients with Severe Reflux Esophagitis. - Severe Reflux Esophagitis in Children from One Year of Age and Older • Maintenance Treatment for the Prevention of Relapse in Patients with Poorly Responsive Peptic Ulcer.• Zollinger-Ellison Syndrome.• Treatment and prevention of NSAID – associated duodenal and gastric ulcers or erosions in high risk patients.

Date de l'autorisation:

2013-05-01